Anti-inflammatory drugs as anticancer agents
S Zappavigna, AM Cossu, A Grimaldi… - International journal of …, 2020 - mdpi.com
Inflammation is strictly associated with cancer and plays a key role in tumor development
and progression. Several epidemiological studies have demonstrated that inflammation can …
and progression. Several epidemiological studies have demonstrated that inflammation can …
Drug resistance and the solid tumor microenvironment
O Trédan, CM Galmarini, K Patel… - Journal of the National …, 2007 - academic.oup.com
Resistance of human tumors to anticancer drugs is most often ascribed to gene mutations,
gene amplification, or epigenetic changes that influence the uptake, metabolism, or export of …
gene amplification, or epigenetic changes that influence the uptake, metabolism, or export of …
[HTML][HTML] Anti-inflammatory agents for cancer therapy
ER Rayburn, SJ Ezell, R Zhang - Molecular and cellular …, 2009 - ncbi.nlm.nih.gov
Inflammation is closely linked to cancer, and many anti-cancer agents are also used to treat
inflammatory diseases, such as rheumatoid arthritis. Moreover, chronic inflammation …
inflammatory diseases, such as rheumatoid arthritis. Moreover, chronic inflammation …
Therapeutic potential of natural products in treatment of cervical cancer: a review
SH Park, M Kim, S Lee, W Jung, B Kim - Nutrients, 2021 - mdpi.com
Cervical cancer is the fourth most common cancer among women worldwide. Though
several natural products have been reported regarding their efficacies against cervical …
several natural products have been reported regarding their efficacies against cervical …
Interstitial fluid pressure as an emerging biomarker in solid tumors
The physical microenvironment of cancer is characterized by elevated stiffness and tissue
pressure, the main component of which is the interstitial fluid pressure (IFP). Elevated IFP is …
pressure, the main component of which is the interstitial fluid pressure (IFP). Elevated IFP is …
Overcoming key biological barriers to cancer drug delivery and efficacy
SM Kim, PH Faix, JE Schnitzer - Journal of Controlled Release, 2017 - Elsevier
Poor delivery efficiency continues to hamper the effectiveness of cancer therapeutics
engineered to destroy solid tumors using different strategies such as nanocarriers, targeting …
engineered to destroy solid tumors using different strategies such as nanocarriers, targeting …
The Interaction of Human Papillomavirus Infection and Prostaglandin E2 Signaling in Carcinogenesis: A Focus on Cervical Cancer Therapeutics
J García-Quiroz, B Vázquez-Almazán… - Cells, 2022 - mdpi.com
Chronic infection by high-risk human papillomaviruses (HPV) and chronic inflammation are
factors associated with the onset and progression of several neoplasias, including cervical …
factors associated with the onset and progression of several neoplasias, including cervical …
Carcinoma and other tumors of the cervix
TC Wright, A Ferenczy, RJ Kurman - … pathology of the female genital tract, 1994 - Springer
Abstract The World Health Organization (WHO) classification for tumors of the cervix has
been revised recently in collaboration with the International Society of Gynecological …
been revised recently in collaboration with the International Society of Gynecological …
[HTML][HTML] The role of PET/CT in cervical cancer
FG Herrera, JO Prior - Frontiers in oncology, 2013 - frontiersin.org
In locally advanced cervical cancer, 18F-fluorodeoxyglucose (FDG) positron emission
tomography–computed tomography (PET/CT) has become important in the initial evaluation …
tomography–computed tomography (PET/CT) has become important in the initial evaluation …
[HTML][HTML] The role of galectins in cervical cancer biology and progression
L Wang, Y Zhao, Y Wang, X Wu - BioMed research international, 2018 - hindawi.com
Cervical cancer is one of the malignant tumors with high incidence and high mortality among
women in developing countries. The main factors affecting the prognosis of cervical cancer …
women in developing countries. The main factors affecting the prognosis of cervical cancer …